RxDoctor Payments Data

Edward Booker, MD

Family Medicine · West Union, SCNPI 1669539839

Payments from drug & device makers

$9,044in general payments, 2019–2025

Across 614 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • AstraZeneca$761
  • Lilly USA, LLC$719
  • GSK$540
  • Otsuka America Pharmaceutical, Inc.$503
  • plus $4K from 35 others

What the payments were for

  • Food & beverage$9,028100%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,044 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$110,839
Medicare patients
307
Services billed
1,964

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin128$90,253
OtezlaApremilast17$77,072
VraylarCariprazine Hcl31$42,196
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$40,923
MounjaroTirzepatide35$39,995
TrulicityDulaglutide31$39,362
OzempicSemaglutide28$26,787
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog27$25,348
EliquisApixaban33$24,913
RybelsusSemaglutide24$23,101
FarxigaDapagliflozin Propanediol31$22,510
XareltoRivaroxaban30$19,282
Synjardy XrEmpagliflozin/Metformin Hcl17$13,469
LinzessLinaclotide16$11,269
BelsomraSuvorexant20$10,010

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr$54$103,722145 claims
Lilly USA, LLCMounjaro, Trulicity$719$79,35766 claims
AmgenOtezla$475$77,07217 claims
AbbVieVraylar, Linzess$1,368$53,46547 claims
Novo NordiskOzempic, Rybelsus$1,190$49,88852 claims
GSKTrelegy Ellipta, Anoro Ellipta$540$46,28258 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$761$35,78359 claims
PfizerEliquis$279$24,91333 claims
Johnson & JohnsonXarelto$118$19,28230 claims
MerckBelsomra$93$10,01020 claims
Astellas Pharma US IncMyrbetriq$88$9,30321 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$183$3,19211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in West Union

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →